Transitions of care from the emergency department (ED) represent a period of heightened vulnerability for older adults, driven by medical complexity, functional impairment, and social factors.
A new Johns Hopkins analysis of 205,896 branded medication fills offers the first national look inside the prior authorization process — tracking how long patients wait, who gets approved, and who bears the cost.
he article review the challenges and lack of robust biologics market competition and drug pricing impacts, the history of the small molecule generics marketplace and the subsequent early evolution of the biosimilar marketplace.
The Medicare Advantage Star Ratings program has operated for decades and directs billions of dollars in quality bonus payments, yet little is known about which measures have driven observed performance improvement over time.
The authors argue that Maryland's next phase of payment reform must move beyond hospital global budgets to engage frontline clinicians in population health, outlining priorities for the new AHEAD model including population-based payments, expanded incentives, and regulatory modernization.
This tutorial paper demonstrates the application of a conceptual model to measure racial and ethnic disparities in treatment intensification among adults with hypertension consistent with the Institute of Medicine (IOM) definition.
Using nationally representative data, we found that for common physician-administered drugs, hospitals' cash prices are frequently lower than their median-and sometimes even their lowest-commercial negotiated prices.
